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SUMMARY
Eosinophils are now recognized as multifunctional
leukocytes that provide critical homeostatic signals
to maintain other immune cells and aid tissue repair.
Paradoxically, eosinophils also express an armory
of granule-localized toxins and hydrolases believed
to contribute to pathology in inflammatory disease.
How eosinophils deliver their supporting functions
while avoiding self-inflicted injury is poorly under-
stood. We have demonstrated that cystatin F (CF) is
a critical survival factor for eosinophils. Eosinophils
from CF null mice had reduced lifespan, reduced
granularity, and disturbed granule morphology.
In vitro, cysteine protease inhibitors restored granu-
larity, demonstrating that control of cysteine prote-
ase activity by CF is critical for normal eosinophil
development. CF null mice showed reduced pulmo-
nary pathology in a model of allergic lung inflamma-
tion but also reduced ability to combat infection
by the nematode Brugia malayi. These data identify
CF as a ‘‘cytoprotectant’’ that promotes eosinophil
survival and function by ensuring granule integrity.
INTRODUCTION
Eosinophils are leukocytes that contain abundant granules
whose toxic protein content provides protection against some
helminths and other pathogens but additionally, and less desir-
ably, have a deleterious impact during allergic disease. Recent
reports have identified important new functions for eosinophils,
which are now considered to be multifunctional leukocytes that
combine cytotoxicity with key roles in maintaining other immune
cells and in tissue homeostasis (Akuthota et al., 2008; Rosenberg
et al., 2013). For example, long-term maintenance of plasma
cells in the bone marrow depends on production of interleukin-
6 (IL-6) and the B cell survival factor APRIL by eosinophils and
in the gut eosinophil-derived transforming growth factor-b1
(TGF-b1) promotes antibody class switching to immunoglobulin
A (IgA) and maintains gut-associated regulatory T cells and
mucosal integrity (Berek, 2015). Inmurine adipose tissue alterna-
tively activated macrophages are maintained by IL-4 produced
by local eosinophils, whose absence led to insulin resistance
and metabolic disease (Wu et al., 2011). Similarly, eosinophil-
derived IL-4 is critical for muscle repair mediated by fibro/adipo-
cyte progenitors (Heredia et al., 2013). Eosinophils have been
identified as key effector cells in IL-23-driven colitis (Griseri
et al., 2015) and also as professional antigen-presenting cells
(Akuthota et al., 2008).
Theabundantgranulesof eosinophils contain abattery of highly
toxic proteins including major basic proteins (MBP) 1 & 2, eosino-
phil peroxidase (Epx), eosinophil cationic protein, and eosinophil-
derived neurotoxin (Hogan et al., 2008). Upon release from
granules, these proteins are toxic not only to bacterial, viral, and
helminth pathogens but also to host cells and tissues (Furuta
et al., 2005; Lee et al., 2004; Simon et al., 2010). Several studies
link granule proteins to human eosinophil-linked diseases that
affect the airways and esophagus. Taken together, the current
picture presents a conundrum. How can eosinophils be both
cytotoxic yet also provide a supportive environment for homeo-
static processes? In particular, how does the eosinophil safely
sequester its payload of toxic proteins to ensure its own survival?
We have identified a survival factor for eosinophils called
cystatin F.
The cystatins are naturally occurring proteins that potently
inhibit the C1 family of cysteine proteases including cathepsins
L, B, S, and C (Abrahamson et al., 2003; Turk et al., 2008). Cys-
tatin F (CF), also known as ‘‘leukocystatin’’ because of its almost
exclusive expression in immune cells, is a structurally unique
member of the family being made as a disulphide-linked dimer
(Cappello et al., 2004; Schu¨ttelkopf et al., 2006). We have shown
previously that dimeric CF is inactive because each sub-unit ste-
rically inhibits the other’s ability to bind proteases (Schu¨ttelkopf
et al., 2006). In living cells, CF dimers are activated by proteolysis
of the N-terminal region that links one monomer to its partner
(Hamilton et al., 2008). Whereas other cystatins made with signal
sequences are mostly secreted from cells, CF is targeted to the
endocytic pathway (Nathanson et al., 2002) via the mannose-6-
phosphate receptor (Colbert et al., 2009). The structure and
mode of activation of CF suggests a unique mechanism for
‘‘buffering’’ vacuolar protease activity but which leukocytes
might require this is not known. In this study, we generated CF
null mice and report that CF is a critical survival factor for eosin-
ophils. In its absence, granule biogenesis was abnormal and
eosinophil survival was impaired. Consequently, CF null mice
showed reductions in eosinophil-mediated allergic pathology
and diminished protection against the nematode Brugia malayi.
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RESULTS
Absence of Normal Eosinophils in CF Null Mice
To determine the impact of CF ablation on leukocyte popula-
tions, we generated CF null mice by loxP-mediated excision of
exon 2 of the CF-encoding gene Cst7 removing a substantial
part of the coding sequence to produce a frameshift of down-
stream sequences (Figure S1A). Protein expression was lost in
all tissues including lymph node and spleen (Figure S1B) and in
the granular leukocytes where CF is most abundantly expressed
including CD8+ and gd T cells, neutrophils and eosinophils (Fig-
ure S1C). Grossmorphology of lymphoid organswas unchanged
in CF null mice. Because CF is found in leukocyte granules (Ham-
ilton et al., 2008) we assessed not only leukocyte numbers,
which appeared essentially normal in naive null mice (Figure S2),
but also cell granularity as assessed by flow cytometry side-
scatter (SSC). In blood, bone marrow and in other tissues we
consistently found that Siglec-F+ eosinophils from CF null mice
had very low SSC relative to wild-type (WT) eosinophils (Fig-
ure 1A and Figure S2). Although steady-state eosinophil produc-
tion in the bone marrow was essentially the same in WT and CF
null mice, in blood, and especially in the lung, significantly more
CF null eosinophils became BrdU positive over a 48 hr period
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Figure 1. CF Null Eosinophils HaveReduced
Granularity and Compromised Survival in
Peripheral Tissues
(A) Analysis of eosinophil granularity and turnover
in naive mice. BrdU incorporation was assessed in
the indicated tissues 48 hr after administration of a
single dose of BrdU. Representative contour plots
are shown together withmeans ± SD for threemice
per group.
(B and C) Mice were sensitized & challenged with
OVA to induce acute eosinophilic lung inflamma-
tion. (B) Representative flow cytometry plots gated
on total live (DAPI) BAL cells from allergic mice
showing absence of high SSC eosinophils. (C)
Leukocyte and eosinophil accumulation in the air-
waysand in theperipheral circulationaredecreased
in Cst7/ mice during acute allergic inflammation.
The frequencyof apoptotic eosinophils (AnnexinV+,
DAPI) was assessed by flow cytometry and is also
shown. Data represent individual mice plus means
and are from 1 of 5 experiments with similar
outcome. See also Figures S2 and S3.
implying faster turnover of this population
of granulocytes (Figure 1A).
We asked whether the accelerated
turnover of CF null eosinophils in the
lung might be due to impaired survival
upon activation potentially leading to dif-
ferences in eosinophil numbers during
conditions of active eosinophilic inflam-
mation. To test this, we used a model
of ovalbumin-specific allergic lung in-
flammation. As expected, this led to
the recruitment of large numbers of eo-
sinophils with high SSC. These cells
were almost completely absent in CF-
deficient animals and were replaced by Siglec F+ cells with
much reduced granularity (Figures 1B and S3). Moreover, under
these conditions there was a dramatic reduction both in the
total inflammatory cell infiltrate in the airways of CF null
mice and in the accumulation of eosinophils, which was
70% lower than in WT mice (Figures 1C and S3). In contrast,
neutrophil, dendritic cell, and other leukocyte numbers were
unchanged (Figure S3). The shortfall in lung eosinophilia could
not be explained by decreased eosinophil generation since
even under allergic conditions there were equivalent numbers
of eosinophils in the bone marrow of CF null and WT mice
(data not shown). Nevertheless, blood eosinophilia increased
3 fold in allergic WT mice but significantly less so in CF null
mice (Figure 1C). Consistent with the reduction in lung eosino-
philia, we also observed a significantly higher incidence of
Annexin V+, DAPI ‘‘early’’ apoptotic eosinophils in the CF
null mouse lungs, indicating eosinophil death in the absence
of CF (Figure 1C).
The Requirement for CF Is Cell Autonomous
We next asked whether the phenotype was due to lack of CF
in eosinophils or, for example, in another cell type that sup-
ports normal eosinophil development. We reconstituted lethally
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irradiated mice with equal numbers of bone marrow cells from
WT (CD45.1) and CF null (CD45.2) mice. Six weeks after recon-
stitution, we monitored repopulation in the blood and bone
marrow. As shown in Figure 2A, WT eosinophils outnumbered
CF null eosinophils after reconstitution whereas other leuko-
cytes were equally efficiently populated by WT and null cells.
Moreover, eosinophils that were established from CF null
marrow had much reduced SSC confirming an eosinophil-
intrinsic requirement for CF (Figure 2A). To establish unequivo-
cally that loss of CF accounted for the phenotype, we attemp-
ted to rescue normal eosinophil granularity and numbers by
CF re-expression. Donor bone marrow, consisting of a mix-
ture of WT and CF null cells, was transduced with a retrovirus
expressing CF and, via an IRES element, eGFP. After reconsti-
tution, we established allergic inflammation in the lung as
described above and analyzed eGFP as a marker of CF expres-
sion in eosinophil and non-eosinophil populations. As shown in
Figure 2B, less than 5% of WT eosinophils expressed eGFP
whereas >90% of CF null eosinophils were eGFP+ demon-
strating a very strong selection for eosinophils with restored
CF expression. In contrast, few non-eosinophil leukocytes
became GFP+ confirming that CF does not advantage other
lineages (Figure 2B). In addition, although CD45.2+, eGFP
eosinophils retained the CF null low SSC phenotype, granu-
larity of the rescued eGFP+, CF+ fraction was completely
restored to that of WT demonstrating that not only eosinophil
numbers but also granularity was rescued by CF re-expression
(Figure 2B).
A
B
Figure 2. Mixed Radiation Chimerae
Demonstrate a Cell Autonomous Require-
ment for CF in Eosinophils
(A) Lethally irradiated mice were reconstituted with
equal numbers of CD45.1+ WT and CD45.2+
Cst7/ or WT bone marrow cells. Leukocyte
repopulation was assessed in bone marrow (top
panels) and peripheral blood (lower) 6 weeks later.
Data (means ± SEM, n = 5 per group) were
normalized by dividing the percent reconstitution in
the eosinophil compartment by that in non-eosin-
ophil leukocytes for each donor genotype to
determine reconstitution efficiency.
(B) Irradiated CD45.1+ hosts were reconstituted
with mixed WT and Cst7/ donor cells infected
with retrovirus expressing eGFP and CF. Five
weeks later, mice were sensitized to OVA and
allergic lung inflammation was induced with nebu-
lized OVA. BAL cells were analyzed by flow cy-
tometry and eosinophils identified asWT (CD45.1+)
or CF null (CD45.1). Reconstitution of CF (indi-
cated by eGFP expression) rescues eosinophil
numbers and completely restores granularity as
assessed by SSC (histogram overlay). Few non-
eosinophil CD45.2+ leukocytes expressed CF indi-
cating that CF does not confer a survival advantage
in other compartments. Histograms show rescue of
granularity (SSC; means ± SD) and proportion of
cells expressing eGFP (means ± SEM) (n = 4).
Reduced numbers of eosinophils and
abnormal granularity might indicate a
developmental abnormality. However, as
shown in Figure S4A, IL-5Ra+, c-Kitlo eosinophil precursors
were present in normal numbers in CF null bone marrow as
were upstream granulocyte macrophage precursors. Moreover,
blood eosinophil granularity was unaffected by loss of the widely
expressed cystatin, cystatin C (Figure S5). Taken together, these
data suggest a non-redundant requirement for CF in eosinophils
at some point downstream of their expansion from bone marrow
progenitors.
The Granule Ultrastructure of CF Null Eosinophils Is
Highly Abnormal
To understand the cell biological basis of low granularity and
truncated eosinophil lifespan in the absence of CF, we examined
eosinophils purified from the bone marrow of allergic WT and CF
null mice by transmission electronmicroscopy. As expected,WT
eosinophils had numerous granules many with a distinct major
basic protein (MBP)-rich crystalloid core (Popken-Harris et al.,
1998) (Figures 3A and 3C). The appearance of CF null eosino-
phils was radically different (Figures 3A and 3B). Most cells
contained large granules that had an extensive electron lucent
periphery and internal material, which was sometimes
condensed but was more often amorphous and unstructured
(Figures 3A, 3D–3G). Only rarely did lucent granules contain a
classical ‘‘bar-like’’ crystalloid core. In some instances, granule
profiles appeared incomplete, suggesting release of granule
contents into the cytosol (Figures 3A, 3F, and 3G). We also
observed vacuolar structures, which were most likely either
empty granules or granules that had failed to accumulate
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sufficient electron densematerial to be detected.We quantitated
granule numbers per nuclear profile distinguishing between
normal condensed granules and those that appeared disrupted
or otherwise unstructured. Despite these substantial differences
in morphology the frequency of all granular structures was not
significantly different betweenWT and CF null eosinophils. How-
ever, as shown in Figure 3B, WT eosinophils had 4-fold greater
numbers of normal granules compared with CF null eosinophils.
Reduced numbers of dense, light-scattering crystalloid granules
in CF null eosinophils explains their unusual flow cytometric
properties (Figure 1B). Moreover, ultrastructural profiles that
indicate release of toxic granule content to the cytosol might
explain reduced survival of CF null eosinophils.
CF Is Required for Normal In Vitro Generated
Eosinophils but Not Other Granulocytes
We next asked whether eosinophils differentiated in vitro from
bone marrow precursors also required CF for normal granularity
and survival. We adopted the protocol described by Dyer and
colleagues using IL-5 to generate eosinophils from bone marrow
precursors expanded in stem cell factor (SCF-1) and fms-related
kinase 3-ligand (Flt3-L) (Dyer et al., 2008). Although the WT eo-
sinophils generated were less granular than those analyzed
directly ex vivo, in vitro-generated CF null Siglec F+ cells had
an even lower SSC confirming a cell intrinsic CF requirement
for normal granularity (Figure 4A). Consistent with this, and in
agreement with the frequent absence of the crystalline granule
A
B
Figure 3. Abnormal Granule Architecture in CF Null Eosinophils
(A) Electron micrographs of ex vivo bone marrow eosinophils purified from OVA-allergic WT (a and c) or Cst7/ mice (b, d–g). WT eosinophils contain many
characteristic compact rod-like granules with electron lucent crystalline cores and a dense matrix as indicated by arrows (a and c), and also condensed granules
lacking a detectable crystalline core (*). Far fewer normal granules are found in CF null eosinophils (b and d), which instead contain many larger partially
condensed (arrowhead) or uncondensed granules (white arrow) and, occasionally, no electron dense material at all (‘‘vacuoles’’; open arrowhead). Club-like
granule extrusions as shown in (e) were frequently observed and in some cells the limiting membranes appeared incomplete suggesting possible release of
granule contents (arrowhead in f and enlarged in g).
(B) Quantitation of granule morphology in purified eosinophils. Condensed, electron lucent granules with or without a detectable core as described above
(a and c) were considered normal; all other partially or uncondensed granule profiles with irregular or absent matrix (as in b, d–g) were considered disrupted. Data
are means ± SEM of two independent experiments with sorted bone marrow cells from five pooled mice per group. At least 100 cells were counted in each of two
grids per experiment. Scale bars represent 1 mm (a and b) or 0.2 mm (c–g).
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core seen ultrastructurally, the granule constituent MBP-1 was
much reduced relative to WT in CF null in vitro generated eosin-
ophils (Figure 4B) although MBP-1 mRNA transcripts measured
by semiquantitative PCR were essentially the same in both cell
types (data not shown). Some differences in Epx processing in
the CF null cells were also noted but these did not appear to
affect overall Epx protein (Figure 4B) or activity relative to wild-
type (data not shown). The effect of CF ablation on leukocyte
granularity in vitro was specific to the eosinophil because neutro-
phils, basophils, or mast cells expanded from bone marrow pre-
cursors had identical SSC in CF null and WT cells (Figure 4A).
CF Is a Cell Survival Factor for Eosinophils
The results thus far reveal a critical role for CF in maintaining
eosinophil numbers and granularity but not how those two pa-
rameters might be linked. Do high-granule cells fail to develop
in the absence of CF or do they develop but then have a trun-
cated lifespan?We speculated that eosinophil granules and their
constituent toxic proteins might adversely affect host cell
viability and that CF could play an important role as a ‘‘cytopro-
tectant.’’ In this case, cells with a high granule content might be
most vulnerable consistent with their absence when CF is lost.
We tried to resolve these issues both in vivo and with the
in vitro eosinophil culture system. To label newly generated eo-
sinophils in vivo, we treated mice with a 16 hr pulse of BrdU
and examined BrdU+ (new) and negative (older) eosinophils in
A B Figure 4. Reproduction of the CFNull Pheno-
type In Vitro
Reduced granularity is seen in CF null eosinophils
differentiated in vitro but not in other cultured
granulocytes.
(A) Eosinophils, neutrophils, mast cells and baso-
phils were generated from WT or Cst7/ bone
marrow as described in Experimental Procedures.
Histogram overlays show SSC comparisons.
(B) Lysates were prepared from 250,000 cells from
eosinophil cultures at the indicated time points after
addition of IL-5 and separated by reducing SDS-
PAGE for detection of CF, MBP-1, Epx, and actin by
immunoblotting. Data are representative of at least
three independent experiments.
bone marrow. As shown in Figure 5A,
equal numbers of BrdU+ eosinophils were
found in WT and CF null mice but the
granularity of newly generated CF null eo-
sinophils was higher than that of older,
BrdU cells. In contrast, the granularity of
older versus newly generated WT eosino-
phils was the same (Figure 5A). We next
examined differentiation and survival of
eosinophils generated from bone marrow
in vitro. WT and CF null cultures contained
similar numbers of eosinophil precursors
after the 4 day expansion in Flt3-L and
SCF-1 (Figure S4B). As previously
described (Dyer et al., 2008), WT eosino-
phils were detectable within 2 days after
addition of IL-5 and continued to emerge
for a further 10–14 days during which time cell numbers
increased 8–10 fold to comprise >95% eosinophils (Figure 5B).
CF null eosinophil expansion over the same period was generally
lower, but this did not reach significance, consistent with the
normal rate of generation in vivo. However, over longer times
there was a significant loss in viability in the CF null eosinophils
(Figure 5B). To explore this further, we sorted IL-5-expanded eo-
sinophils from WT and CF null bone marrow cultures, into low,
medium, and high SSC populations and recultured them for up
to 12 days in vitro. During this culture period sorted SSChi WT
cells showed a small loss of granularity but CF null eosinophils
exhibited a rapid, irreversible loss of highly granular cells (Fig-
ure 5C). In contrast, SSClo sorted WT cells increased their gran-
ularity over the culture period due presumably to nascent granule
maturation. This occurred to a more limited extent in low granule
CF null cells (Figure 5C). Taken together, these results show that
a small fraction of eosinophils with more abundant granules can
develop in CF null mice but do not survive without CF.
CF Regulates Eosinophil Cysteine Protease Activity to
Ensure Normal Granularity and Viability
Although other functions are not ruled out, CF likely regulates
one or more granule cysteine proteases. Proteomic analysis
of isolated eosinophil granules identified several cysteine ca-
thepsins including cathepsin S, B, Z, C, and L as well as other
lysosomal proteases (Table S1). If disregulated cysteine
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protease activity in CF null mice contributes to eosinophil
granule abnormalities, we reasoned that suppression of such
proteases might restore deficient granularity. In an earlier study,
we have shown that recombinant dimeric CF can be taken
up and activated within the endocytic pathway (Colbert et al.,
2009). Indeed, inclusion of dimeric CF during eosinophil culture
rescued granularity in CF null cells (Figures 6A, 6D, 6E). We also
tested several small molecule protease inhibitors. These exper-
iments were challenging because most inhibitors were toxic
over the time course of eosinophil generation and had to be
carefully titrated. This toxicity was specific to eosinophils as
neutrophil growth was unaffected at the same concentrations
(data not shown). Inclusion of the cysteine protease inhibitors
z-FA-fmk or E64d resulted in a striking rescue of granularity in
CF null eosinophils (Figures 6B–6D) but did not affect the gran-
ularity of WT cells. The rescue of CF null granularity was optimal
at 0.4 mM for both inhibitors, which inhibited approximately 20%
of cathepsin activity in the cells as measured in lysates with the
broad-spectrum substrate z-Phe-Arg-AMC. Higher concentra-
tions inhibited more protease activity but became rapidly toxic
leading to cell death and, at 10 mM z-FA-fmk, a reduction in
WT granularity (Figure 6D). These data strongly suggest that a
primary role of CF is to regulate cysteine protease activity in
developing eosinophils. The toxic effects of cathepsin inhibition
indicate that finely calibrated cysteine protease activity is
required for normal eosinophil development and that CF can
provide such calibration. We next analyzed granule proteins in
rescued cells. The low MBP-1 content in CF null eosinophils
was substantially increased by culturing with dimeric CF (Fig-
ure 6E) a proportion of which was converted to the active mono-
mer (14 kD). In addition, altered Epx processing in CF null
eosinophils was corrected by addition of CF (Figure 6E),
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Figure 5. CF Stabilizes Granule Integrity and Eosinophil Viability
(A) Naive mice received a single dose of BrdU 16 hr before sacrifice & assessment of incorporation into eosinophils in the bone marrow. Example flow cytometry
plots are shown together with means ± SEM from two independent experiments (n = 4 per group).
(B) Bone marrow cells from WT or Cst7/mice were cultured for 4 days in Flt-3L and SCF-1 prior to removal of dead cells by centrifugation over Ficoll-Paque.
One million viable cells were seeded into IL-5 medium and eosinophil expansion and survival was monitored by cell counting and flow cytometric identification of
Siglec F+ cells. Means ± SD of five independent experiments are shown (*p < 0.0005).
(C) In vitro differentiated eosinophils were harvested after 8 days of IL-5 culture, flow cytometry-sorted into populations with high, medium, or low granularity (top
panels), and chased in IL-5 culture for up to 12 days. Granularity of Siglec F+ cells was assessed at the indicated time points. Bottom panel shows change in
granularity over the chase period (means ± SEM from two independent experiments). See also Figure S4.
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although the total amount of Epx protein and activity was un-
changed and equivalent to WT (data not shown). Treatment
with z-FA-fmk, however, prevented the complete conversion
of both MBP-1 and Epx to the mature forms, suggesting that
cysteine proteases participate in this conversion. Together,
these data confirm that CF regulates processing of multiple
granule constituents and support the notion that disturbed
MBP processing is a major cause of the reduced granularity of
CF null eosinophils. Furthermore, the contrasting effects of CF
and z-FA-fmk upon MBP and Epx processing emphasize the
importance of calibrated control of protease activity uniquely
provided by CF for proper granule biogenesis.
Reduced Eosinophil-Dependent Immunopathology and
Protective Immunity in CF Null Mice
Eosinophils have been implicated as key leukocytes in a variety
of immune processes with beneficial or pathological outcomes.
We therefore assessed the impact of loss of CF in a paradigm
of each condition: allergic inflammation and parasite clearance.
First, because eosinophils contribute to airway remodeling in
some mouse models of asthma (Humbles et al., 2004; Lee
et al., 2004) and to pathology in some types of human asthma
(Haldar et al., 2009; Nair et al., 2009), we extended our allergic
lung inflammation studies in CF null mice. During the acute
phase of allergen-induced airway inflammation (day 25), peri-
bronchiolar infiltration of eosinophils (Figure 7A) and mucus pro-
duction by hyperplastic goblet cells (Figure 7B) were significantly
reduced in CF null mice compared toWT.Moreover, the increase
in sub-epithelial matrix deposition observed during the subse-
quent chronic phase of inflammation (days 25–54) was also
significantly attenuated in CF null lungs (Figure 7C). Eosinophils
contribute to the local cytokine milieu enhancing T helper-2 (Th2)
cell responses (Spencer and Weller, 2010). In acutely allergen-
exposed CF null mice several inflammatory cytokines including
tumor necrosis factor-a (TNF-a), interferon-g (IFN-g), and IL-13
were substantially reduced as was Epx activity (Figure S6A).
Taken together, these results show that loss of an eosinophil
granule-localized survival factor leads to attenuated inflamma-
tion and pathological remodeling of the lung.
Finally, we tested the ability of CF null mice to expel the human
nematode parasite Brugia malayi, a major cause of lymphatic
filariasis. Recent studies using eosinophil-deficient mice have
demonstrated a role for eosinophils in protection against primary
infection with B. malayi microfilariae (Mf) (Cadman et al., 2014).
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Figure 6. CF Null Eosinophil Granularity Can Be Stabilized by Inhibition of Cysteine Protease Activity
(A–C) Protease inhibitors were added to in vitro cultured eosinophils after 4 day growth in IL-5 and replenished every other day for 9 days. Histogram overlays
show increase in SSC of Cst7/ eosinophils treated with (A) recombinant mouse CF or with the irreversible broad-spectrum cysteine protease inhibitors z-FA-
fmk (B) and E64d (C).
(D) Quantitation of SSC-rescue with CF and z-FA-fmk. Data are expressed as percent restoration of the difference in mean SSC between control WT & Cst7/
eosinophils; means ± SD of three independent experiments are shown.
(E) Lysates from 200,000 cells cultured as in (D) were separated by reducing SDS-PAGE (z-FA-fmk = 0.4 mM). MBP, Epx, CF, and GAPDH loading control were
detected by immunoblot. Data are representative of at least three independent experiments.
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We infected mice with B. malayi Mf and followed clearance by
blood sampling. WT mice rapidly eliminated the infection, with
Mf burden reduced to undetectable numbers after 28 days in
5 of 6 mice (Figure 7D). In contrast, CF null mice failed to clear
the parasite during this period and this correlated with a delay
in elevated blood eosinophilia (Figure 7D). Mf entrapment in
the pulmonary microvasculature leads to eosinophilic lung
inflammation (Cadman et al., 2014), yet despite the persistence
of Mf in CF null mice upon sacrifice at day 28 of infection there
was a significant reduction in total leukocytes, eosinophils, and
Epx activity in the lung compared to WT (Figures 7D and S6B).
Nonetheless, CF null mice also showed increased IFN-g and
Mf-specific IgE in both sera and BALF at this time point, presum-
ably stimulated by continued presence of the parasite (Fig-
ure S6B). These data demonstrate the importance of maintaining
granule integrity for efficient expansion of eosinophils during hel-
minth infections. Further, they show that CF-mediated control of
cysteine protease activity is an essential component of this
maintenance without which parasite clearance is compromised.
DISCUSSION
Our results have identified CF as a survival factor for eosinophils.
The beneficial effects of CF were most evident in eosinophils
A
B
C D
Figure 7. CF Null Mice Present Reduced
Eosinophil-Dependent Allergic Pathology
and Compromised Antihelminth Immunity
(A) Mice (5–7 per treatment group) were sensitized
to OVA and challenged with OVA aerosol for 5 days
(acute protocol; sacrificed on day 25) or 5 weeks
(chronic protocol; day 54). Pulmonary pathology
was significantly reduced in CF null mice during
both acute and chronic phases of allergen-induced
airway inflammation as assessed by inflammatory
response, mucus staining, and lung remodeling as
follows: (A) H&E-stained lung sections showed
decreased inflammatory infiltrate in the acute
phase; (B) Periodic acid-Schiff staining indicating
reduction in mucus-producing epithelial goblet
cells (magenta) in the CF null airways at d25; (C)
Sirius red detection of subepithelial matrix deposi-
tion visualized under polarized light. For each
analysis, representative images are shown together
with scores for individual mice plus group means.
Scale bars represent 200 mm (original magnification
310) for all images except panels showing mucus
staining (50 mm; original magnification 340).
(D) 100,000 B. Malayi Mf were injected i.v. into WT
(n = 6) or Cst7/ mice (n = 7) and parasite burden
(Mf/ml) and blood eosinophilia were monitored by
blood sampling for 4 weeks (means ± SD; p values:
* < 0.05; **<0.01; ***<0.001). CF null mice signifi-
cantly failed to clear the parasitewithin thiswindow.
Lungs were lavaged on day 28 for total leukocyte
and eosinophil counts. Data represent individual
mice plus means ± SD. See also Figure S6.
with high granule content, a sub-popula-
tion that was essentially absent in CF null
mice. CF is made as an inactive dimer
and is converted to the active monomeric
state by proteolysis (Hamilton et al., 2008). This unique mode of
activation, coupled with its targeting to the endolysosomal
pathway (Colbert et al., 2009), suggests that its function is to
‘‘buffer’’ protease activity in this domain. We propose that as
protease activity rises, for example due to granule condensation
and/or lower pH, more CF dimers will be converted to active
monomers thus normalizing protease activity. Our data show
that this tightly controlled regulation of cysteine proteases is crit-
ical for normal eosinophil granule biogenesis and eosinophil
viability, due at least in part to stabilization of MBP which consti-
tutes the granule core.
Despite the substantial loss of granule integrity, eosinophil
numbers in naive mice were not significantly affected by the
absence of CF. Although BrdU labeling revealed accelerated
eosinophil turnover in CF null lungs, this did not result in a detect-
able reduction in cell numbers, presumably because steady-
state eosinophil development in the bone marrow is sufficient
to maintain the low frequency of eosinophils in naive lungs.
Our observation that CF null eosinophils fail to accumulate nor-
mally during allergic inflammation is in agreement with studies
showing that tissue eosinophilia arises due to delayed eosinophil
apoptosis in response to survival signals such as IL-5 (Simon
et al., 1997). In fact, one consequence of activation of eosino-
phils with IL-5 is rapid granule acidification (Persson et al.,
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2002), which would be expected to lead to increased cysteine
protease activity. In the absence of CF, eosinophils might be un-
able to adequately respond to anti-apoptotic cues, leading to the
dramatic reduction in allergen-induced eosinophilic inflamma-
tion and airway remodeling seen in null mice.
An important question concerns the identity of the proteases
targeted by CF in eosinophils. We reasoned that if unregulated
activity of a single cathepsin is responsible for the phenotype in
CF null eosinophils, genetic deletion of this enzyme might
rescue it. However, we have crossed the CF null mice with
mice lacking individual cathepsins B, S, L, and C but have
not as yet observed a rescue of eosinophil granularity. Most
likely, CF regulates multiple proteases to stabilize granule
formation.
Although CF is expressed in other granule-containing leuko-
cytes such as neutrophils andmast cells, to date the requirement
for CF appears to be eosinophil specific, at least as far as normal
granularity is concerned. It will be of interest to determine
whether the functional properties of other immune cell lineages
are altered by loss of CF. Loss of CF resulted in dramatic
changes to the appearance of eosinophil granules but the pre-
cise events in granule maturation that are disrupted remain to
be characterized. To date, few studies have examined the mo-
lecular biology of granule maturation in eosinophils. MBP is syn-
thesized as a pro-form containing a highly acidic N-terminal
portion that is thought to protect the developing eosinophil
from the mature basic toxin during granule biogenesis (Barker
et al., 1991). Conversion to the mature form, by as yet unidenti-
fied proteases, occurs within the granule itself (Popken-Harris
et al., 1998) and coincides with the formation of inert MBP nano-
crystals, which repress its intracellular toxicity (Soragni et al.,
2015). During degranulation, granule acidification leads to crys-
tal disassembly enabling deposition of smaller highly cytotoxic
MBP aggregates (Soragni et al., 2015). The abnormal granules
we observed in CF null bone-marrow eosinophils were reminis-
cent of immature granules observed in developing eosinophils
(Popken-Harris et al., 1998) perhaps indicative of a failure to
develop properly in the absence of CF.
Other studies have described abnormal eosinophil granularity
but none have replicated the phenotype of CF null eosinophils.
Mice lacking MBP-1 (Prg2/) or Epx (Epx/) have been gener-
ated and their eosinophil granules shown either to lack the crys-
talline core or to contain less matrix respectively (Denzler et al.,
2000; Denzler et al., 2001). In contrast to our results, eosinophil
accumulation and airway histopathology during OVA-induced
allergic inflammation was unaffected in these genetically deleted
mice. This important difference shows that disrupted eosinophil
granule morphology does not necessarily impair eosinophil
viability but rather that precise regulation of cysteine protease
activity during eosinophil development and activation is critical
for survival. Similarly, loss of either of these granule proteins
alone does not impair protection during primary infection with
B. malayiMf (Cadman et al., 2014). The compromised clearance
of this pathogen seen in CF null mice is likely due to a combina-
tion of defective granule integrity and the failure of eosinophils to
rapidly accumulate. Loss of both MBP-1 and Epx together leads
to virtual ablation of the eosinophil lineage due to impaired eosin-
ophil precursor development or survival (Doyle et al., 2013). In
contrast, loss of CF did not affect eosinophil precursor viability,
but rather altered MBP and Epx processing, which appears to
be critical for normal granule biogenesis and biological function.
Although expression of CF is mostly confined to immune cells
its expression in one other instance is noteworthy. An examina-
tion of genes differentially expressed in metastatic versus non-
metastatic murine liver tumors has identified a gene which was
named ‘‘cystatin-like metastasis associated protein’’ or CMAP
(Morita et al., 1999). CMAP expression correlates withmetastatic
activity and tumor volume but its mechanism of action has not
been determined. CMAP is identical to CF raising the possibility
that some transformed cells upregulate CF expression to take
advantage of its cytoprotective properties. Lysosomal cathep-
sins can promote apoptotic cell death via the lysosomal mem-
brane permeabilization (LMP) pathway and there is renewed
interest in selectively inducing this pathway in tumor cells (Pe-
tersen et al., 2013). Elevated CF expression in tumors might
counteract LMP driven cell death by reducing the activity of lyso-
somal cysteine proteases.
Our results extend the concept that cytotoxic leukocytes need
to protect themselves from their own toxic granules. Recent
studies have shown that two members of the serpin family of
serine protease inhibitors, Spi6 and Spi2a, are critical for normal
cytotoxic T lymphocyte (CTL) expansion and survival of memory
cells respectively. Loss of Spi6 leads to self-inflicted death of
CTL through granzyme B leakage into the cytosol reducing
normal CTL expansion (Zhang et al., 2006). In contrast, although
initial expansion of CTL is normal in mice lacking Spi2a, numbers
of memory CD8+ T cells are much reduced due to cathepsin
B mediated programmed cell death (Liu et al., 2004). Unlike
CF, these serpins are located in the cytosol. Our results reveal
a topologically distinct mode of protection that operates in the
lumen of eosinophil granules and possibly other granule contain-
ing leukocytes. Whereas the serpins act to suppress the pro-
apoptotic effects of proteases that leak from CTL granules, CF
acts to prevent granule instability by ensuring normal granule
biogenesis. Thus leukocytes use two distinct families of protease
inhibitors, the serpins and the cystatins, to protect themselves
from self-inflicted lethal hits.
EXPERIMENTAL PROCEDURES
Mice
CF null mice were generated (TaconicArtemis) by deletion of exon 2 of the CF-
encoding geneCst7 as outlined in Figure S1A on a C57BL/6 background. Mice
were bred and maintained under specific pathogen-free conditions and were
used between 6 weeks and 6 months of age. Cst7/ breeding performance
and litter size were comparable to WT. All animal experiments were approved
by the University of Dundee Ethics Committee and were performed under a
United Kingdom Home Office Project License.
Reagents
Polyclonal antisera specific for mouse MBP-1 and Epx were generated by
immunizing rabbits with synthetic peptides coupled to KLH (Scottish National
Blood Transfusion Service) and affinity purified. The immunizing peptides were
MBP: GGRIKGWGRC and Epx: CSRIPKLNLSAWRGK.
Parasite Infection Protocol
Groups of six to seven, 10-week-old male mice were intravenously injected
with 105B. malayiMf as previously described (Cadman et al., 2014). Parasitae-
mia and blood counts were monitored by blood sampling 4, 7, 14, 21, and
28 days after infection. Upon termination airways were sampled by bronchoal-
veolar lavage (BAL).
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Ovalbumin-Induced Airway Inflammation
For induction of acute airways inflammation, mice were primed by intraperito-
neal injection of 10 mg OVA (Sigma) in 100 ml Imject Alum (Thermo Scientific) on
days 0 and 11 followed by daily challenge with an aerosol of 1% OVA from
days 20–24 & sacrifice on day 25. Induction of chronic inflammation and
lung remodeling was identical except that from day 25 mice received addi-
tional challenge with nebulized OVA 3 times per week for 4 weeks before sac-
rifice 24 hr after the last OVA aerosol on day 54. Airways were sampled by BAL
or inflated with 4% isotonic paraformaldehyde for histology.
Histology
4 mm paraffin-embedded lung sections (Veterinary Diagnostic Services, Uni-
versity of Glasgow) were stained with hematoxylin and eosin (H&E) to evaluate
general morphology and with Periodic acid-Schiff (PAS) to identify epithelial
goblet cells. Matrix deposition was assessed on Sirius red-stained sections.
Slides were examined in a random blinded fashion. Leukocytic lung infiltration
was graded with a semiquantitative scoring system on a scale of 0–5, with 1
signifying a small number of inflammatory foci and 5 a large (>3 cells deep)
widespread infiltrate around the majority of vessels and bronchioles. PAS-
stained goblet cells were scored as described (McMillan et al., 2002).
Sirius red staining was visualized under polarized light. Digital photographs
of at least five bronchioles per slide were quantitated with Volocity V6.3.0 (Per-
kin Elmer) using automatic detection and measurement of stained regions.
Data are expressed as the area of staining per mm length of basement
membrane.
Flow Cytometry
All analytical flow cytometry was performed on a BD LSR II flow cytometer.
Dead cells were identified by DAPI (4’,6-diamidino-2-phenylindole) and
excluded from analysis where appropriate. Primary antibodies specific for
the following markers were directly conjugated to FITC, PE, APC, PerCP-
Cy5.5, eFluor-780, eFluor-450, or PE-Cy7 and purchased from eBioscience
(CD3, CD4, CD8a, CD11b, CD16/32, CD34, CD45.1, CD45.2, CD45R(B220),
CD49b(DX5), FcεR1 and Gr1) or from BD Biosciences (c-kit, IL-5Ra, Siglec F,
CCR3, and Annexin V). For intracellular staining, surface-labeled cells were
fixed in isotonic 3% paraformaldehyde and incubated with affinity-purified
anti-CF (Hamilton et al., 2008) in Fix & Perm (Invitrogen) according to product
instructions. Staining was detected with highly cross-adsorbed donkey anti-
rabbit-FITC (Jackson Immunochemicals, Stratech, UK). For cell sorting exper-
iments, eosinophil populations were sorted on a BD Influx flow cytometer.
BrdU Labeling In Vivo
Mice were injected intraperitoneally with a single dose of 100 mg BrdU 16 or
48 hr prior to sacrifice. Single cell suspensions were stained with the relevant
surface antigens and BrdU incorporation was revealed using the APC BrdU
Flow Kit (BD PharMingen).
In Vitro Granulocyte Culture
Eosinophils were differentiated as described (Dyer et al., 2008) with some
modifications. Briefly, bone marrow cells were depleted of erythrocytes
by osmotic lysis and cultured at 106 cells/ml in R20F (RPMI containing
20% FCS, 100 IU/ml penicillin, 10 mg/ml streptomycin, 2 mM glutamine,
13 non-essential amino acids, 1 mM sodium pyruvate (Life Technologies),
and 50 mM b-mercaptoethanol), supplemented with 100 ng/ml stem cell fac-
tor (SCF-1) (eBioscience), and 100 ng/ml Flt-3L (Peprotech). On day 4 cells
were centrifuged at 800 g for 25 min over Ficoll-Paque (GE Healthcare,
UK) to remove dead cells and pre-existing granulocytes. Live cells were
collected from the interface, washed, and cultured at 106/ml in R20F contain-
ing 20 ng/ml recombinant mouse IL-5 (eBioscience), with media refreshed
every 3 or 4 days. Other granulocyte populations were generated identically
to day 4 after which enriched precursor cells were cultured in R20F plus
10ng/ml G-CSF for 6 days (for neutrophil generation) or 20 U/ml mIL-3 for
up to 25 days (for basophil and mast cell differentiation). For rescue experi-
ments, recombinant mouse CF or the inhibitors z-FA-fmk and E64d (Sigma)
were added to eosinophil cultures after 4 days expansion in IL-5. Every two
days half the medium was replaced with the same volume of fresh inhibitor at
the same concentration.
Immuno Blotting
Eosinophils were lysed in 10 mM Tris (pH7.4) containing 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 0.5% CHAPS, and 0.1% NP-40. Samples were separated
by reducing SDS-PAGE on 10% Bis-Tris gels (Invitrogen), transferred to nitro-
cellulose membranes and blocked and probed in 5% milk powder in PBS/
0.05% Tween-20. Rabbit antibodies and actin-specific C4 were detected
with peroxidase-conjugated secondary antibodies (Jackson) and Immobilon
chemiluminescent substrate (Millipore).
Transmission Electron Microscopy
Single cell suspensions were prepared from bone marrow of OVA-immunized
and challenged mice and depleted of irrelevant leukocytes using anti-rat IgG
beads (Dynal Invitrogen) and antibodies specific for CD3, CD4, CD8, Ter119,
and B220. The remaining cells were labeled with anti-Siglec F and anti-Gr1
and viable eosinophils (Siglec F+, Gr1lo, DAPI–) were enriched by flow cytom-
etry to greater than 95% purity, fixed in 2% glutaraldehyde, 0.1M sodium
cacodylate, pH 7.3, and sections mounted on electron microscopy grids.
Images were recorded on a JEOL 1200 EX (80kV) with phospho-imaging
plates (DITABIS, Pforzheim). For quantitation, multiple fields were selected
by random sampling under high magnification (340,000) and total numbers
of nuclear membrane profiles, plasma membrane profiles, and subcellular or-
ganelles were counted in each field. At least 100 nuclear membrane profiles
were counted per sample and data were normalized by dividing the total of
each organelle by the number of nuclear membrane profiles counted.
Radiation Chimerae and Retroviral Infections
For mixed bonemarrow radiation chimerae, host mice were irradiated with 23
6 Gy delivered 3 hr apart and reconstituted by intravenous injection of 23 106
donor cells comprising equal numbers of freshly isolatedWT andCst7/ bone
marrow. WT donor cells were derived from congenic C57BL/6 mice express-
ing CD45.1 to enable discrimination from CD45.2+ Cst7/ cells in the recon-
stituted chimerae.
In some experiments, donor cells were infected with retroviruses express-
ing mouse CF and GFP. CF was cloned from spleen cDNA and inserted into
the Moloney murine leukemia virus (MoMLV)-based pBMN-I-eGFP retroviral
vector (provided by G. Nolan, Stanford) (Hamilton et al., 2008). Virus was pro-
duced by transfection of Phoenix Eco 293T packaging cells as previously
described (West et al., 2004). Donor mice were injected intraperitoneally
with 5 mg 5-fluoro-uracil and bone marrow cells were collected 3 days later,
incubated overnight in culture media containing 10 ng/mL IL-3, 10 ng/mL
IL-6, and 50 ng/mL SCF-1 (Peprotech), and infected with retrovirus in
5 mg/ml polybrene by centrifugation at 1,000 g 3 90 min. Infection was
repeated following overnight culture and plates incubated for a further 4 hr
before counting cells, mixing WT and Cst7/ and injecting into irradiated
donor mice.
Eosinophil Peroxidase Assay
Epx activity was measured essentially as described (Clark et al., 2004) using
12 mM O-phenylene diamine in 10 mM HEPES pH 8 containing 0.25% cetyl-
tetraethylammonium bromide and 0.01% hydrogen peroxide. 50 ml substrate
solution was added to an equal volume of BAL supernatant or eosinophil lysate
for 20 min at 21C. Reactions were terminated with 5% phosphoric acid and
absorbance measured at 490 nm.
Data Analysis
For repeated-measurements in the parasite expulsion studies, two-way
ANOVA was used to test for effects between groups. All other data were
analyzed using the unpaired t test or, for animal experiments, the Mann-Whit-
ney U test (Prism 6, Graphpad Software). Statistical significancewas accepted
when p < 0.05.
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